Drug interactions for the following drug(s)

Interactions between your selected drugs

Magnesium hydroxide can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.

The serum concentration of Levothyroxine can be decreased when it is combined with Aluminum hydroxide.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 307746, name = aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to magnesium hydroxide, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Magnesium hydroxide and Levothyroxine. Drug1 is resolved to aluminum hydroxide, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Aluminum hydroxide and Levothyroxine.

Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 307746, name = aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to aluminum hydroxide, dried (USP) and interaction asserted in DrugBank between Levothyroxine and Aluminum hydroxide.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.